Global Opioid Induced Constipation (OIC) Drugs Market Status and Future Forecast 2015-2024


Report ID : RNR-248850 Category : Medical Devices Published Date : 10-Mar-19
Publisher : 99Strategy Pages : 158 Format : PDF
Summary
The report forecast global Opioid Induced Constipation (OIC) Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024.

The report offers detailed coverage of Opioid Induced Constipation (OIC) Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Opioid Induced Constipation (OIC) Drugs  by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Opioid Induced Constipation (OIC) Drugs  market for 2015-2024.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Opioid Induced Constipation (OIC) Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Opioid Induced Constipation (OIC) Drugs company.

Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Drug Type, Prescription Type, Application & Region
Part 2:
Global Market by company, Drug Type, Prescription Type, Application & Geography
Part 3-4:
Asia-Pacific Market by company, Drug Type, Prescription Type, Application & Geography
Part 5-6:
Europe Market by company, Drug Type, Prescription Type, Application & Geography
Part 7-8:
North America Market by company, Drug Type, Prescription Type, Application & Geography
Part 9-10:
South America Market by company, Drug Type, Prescription Type, Application & Geography
Part 11-12:
Middle East & Africa Market by company, Drug Type, Prescription Type, Application & Geography
Part 13:
Company information, Sales, Cost, Margin etc.
Part 14:
Conclusion
Market Segment as follows:
By Region
        Global (Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]) 
Key Companies
    Ironwood Pharmaceuticals Inc
    Daiichi Sankyo Co Ltd
    Pfizer
    Progenics Pharmaceuticals Inc
    Shionogi & Co., Ltd
    Allergan Plc
    Nektar Therapeutics
    Purdue Pharma
    S.L.A. Pharma AG
    Mundipharma International Limited
    Ono Pharmaceutical Co., Ltd
    Takeda Pharmaceutical Company Limited
    Theravance Biopharma Inc
    Valeant Pharmaceuticals International
    Cosmo Pharmaceuticals SA
    Daewoong Pharmaceutical
    C.B. Fleet Company
    Sucampo Pharmaceuticals
Market by Drug Type
    Lubiprostone
    Methyl Naltrexone Bromide
    Naldemedine
    Alvimopan
    Others
Market by Prescription Type
    Generic and Branded Prescribed Drugs
    Over The Counter Drugs
Market by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
Part 1 Market Overview
    1.1 Market Definition
    1.2 Market Development
    1.3 ByDrug Type
    1.4 By Prescription Type
    1.5 By Application
    1.6 By Region
Part 2 Global Market Status and Future Forecast
    2.1 Global Market by Region
    2.2 Global Market by Company
    2.3 Global Market by Drug Type
    2.4 Global Market by Prescription Type
    2.5 Global Market by Application
    2.6 Global Market by Forecast
Part 3 Asia-Pacific Market Status and Future Forecast
    3.1 Asia-Pacific Market by Company
    3.2 Asia-Pacific Market by Drug Type
    3.3 Asia-Pacific Market by Prescription Type
    3.4 Asia-Pacific Market by Application
    3.5 Asia-Pacific Market by Forecast
Part 4 Asia-Pacific Market by Geography
    4.1 China Market Status and Future Forecast
        4.1.1 China Market by Drug Type
        4.1.2 China Market by Prescription Type
        4.1.3 China Market by Application
        4.1.4 China Market by Forecast
    4.2 Southeast Asia Market Status and Future Forecast
        4.2.1 Southeast Asia Market by Drug Type
        4.2.2 Southeast Asia Market by Prescription Type
        4.2.3 Southeast Asia Market by Application
        4.2.4 Southeast Asia Market by Forecast
    4.3 India Market Status and Future Forecast
        4.3.1 India Market by Drug Type
        4.3.2 India Market by Prescription Type
        4.3.3 India Market by Application
        4.3.4 India Market by Forecast
    4.4 Japan Market Status and Future Forecast
        4.4.1 Japan Market by Drug Type
        4.4.2 Japan Market by Prescription Type
        4.4.3 Japan Market by Application
        4.4.4 Japan Market by Forecast
    4.5 Korea Market Status and Future Forecast
        4.5.1 Korea Market by Drug Type
        4.5.2 Korea Market by Prescription Type
        4.5.3 Korea Market by Application
        4.5.4 Korea Market by Forecast
    4.6 Oceania Market Status and Future Forecast
        4.6.1 Oceania Market by Drug Type
        4.6.2 Oceania Market by Prescription Type
        4.6.3 Oceania Market by Application
        4.6.4 Oceania Market by Forecast
Part 5 Europe Market Status and Future Forecast
    5.1 Europe Market by Region
    5.2 Europe Market by Company
    5.3 Europe Market by Drug Type
    5.4 Europe Market by Prescription Type
    5.5 Europe Market by Application
    5.6 Europe Market by Forecast
Part 6 Europe Market by Geography
    6.1 Germany Market Status and Future Forecast
        6.1.1 Germany Market by Drug Type
        6.1.2 Germany Market by Prescription Type
        6.1.3 Germany Market by Application
        6.1.4 Germany Market by Forecast
    6.2 UK Market Status and Future Forecast
        6.2.1 UK Market by Drug Type
        6.2.2 UK Market by Prescription Type
        6.2.3 UK Market by Application
        6.2.4 UK Market by Forecast
    6.3 France Market Status and Future Forecast
        6.3.1 France Market by Drug Type
        6.3.2 France Market by Prescription Type
        6.3.3 France Market by Application
        6.3.4 France Market by Forecast
    6.4 Italy Market Status and Future Forecast
        6.4.1 Italy Market by Drug Type
        6.4.2 Italy Market by Prescription Type
        6.4.3 Italy Market by Application
        6.4.4 Italy Market by Forecast
    6.5 Russia Market Status and Future Forecast
        6.5.1 Russia Market by Drug Type
        6.5.2 Russia Market by Prescription Type
        6.5.3 Russia Market by Application
        6.5.4 Russia Market by Forecast
    6.6 Spain Market Status and Future Forecast
        6.6.1 Spain Market by Drug Type
        6.6.2 Spain Market by Prescription Type
        6.6.3 Spain Market by Application
        6.6.4 Spain Market by Forecast
    6.7 Netherlands Market Status and Future Forecast
        6.7.1 Netherlands Market by Drug Type
        6.7.2 Netherlands Market by Prescription Type
        6.7.3 Netherlands Market by Application
        6.7.4 Netherlands Market by Forecast
    6.8 Turkey Market Status and Future Forecast
        6.8.1 Turkey Market by Drug Type
        6.8.2 Turkey Market by Prescription Type
        6.8.3 Turkey Market by Application
        6.8.4 Turkey Market by Forecast
    6.9 Switzerland Market Status and Future Forecast
        6.9.1 Switzerland Market by Drug Type
        6.9.2 Switzerland Market by Prescription Type
        6.9.3 Switzerland Market by Application
        6.9.4 Switzerland Market by Forecast
Part 7 North America Market Status and Future Forecast
    7.1 North America Market by Region
    7.2 North America Market by Company
    7.3 North America Market by Drug Type
    7.4 North America Market by Prescription Type
    7.5 North America Market by Application
    7.6 North America Market by Forecast
Part 8 North America Market by Geography
    8.1 United States Market Status and Future Forecast
        8.1.1 United States Market by Drug Type
        8.1.2 United States Market by Prescription Type
        8.1.3 United States Market by Application
        8.1.4 United States Market by Forecast
    8.2 Canada Market Status and Future Forecast
        8.2.1 Canada Market by Drug Type
        8.2.2 Canada Market by Prescription Type
        8.2.3 Canada Market by Application
        8.2.4 Canada Market by Forecast
    8.3 Mexico Market Status and Future Forecast
        8.3.1 Mexico Market by Drug Type
        8.3.2 Mexico Market by Prescription Type
        8.3.3 Mexico Market by Application
        8.3.4 Mexico Market by Forecast
Part 9 South America Market Status and Future Forecast
    9.1 South America Market by Region
    9.2 South America Market by Company
    9.3 South America Market by Drug Type
    9.4 South America Market by Prescription Type
    9.5 South America Market by Application
    9.6 South America Market by Forecast
Part 10 South America Market by Geography
    10.1 Brazil Market Status and Future Forecast
        10.1.1 Brazil Market by Drug Type
        10.1.2 Brazil Market by Prescription Type
        10.1.3 Brazil Market by Application
        10.1.4 Brazil Market by Forecast
    10.2 Argentina Market Status and Future Forecast
        10.2.1 Argentina Market by Drug Type
        10.2.2 Argentina Market by Prescription Type
        10.2.3 Argentina Market by Application
        10.2.4 Argentina Market by Forecast
    10.3 Columbia Market Status and Future Forecast
        10.3.1 Columbia Market by Drug Type
        10.3.2 Columbia Market by Prescription Type
        10.3.3 Columbia Market by Application
        10.3.4 Columbia Market by Forecast
    10.4 Chile Market Status and Future Forecast
        10.4.1 Chile Market by Drug Type
        10.4.2 Chile Market by Prescription Type
        10.4.3 Chile Market by Application
        10.4.4 Chile Market by Forecast
    10.5 Peru Market Status and Future Forecast
        10.5.1 Peru Market by Drug Type
        10.5.2 Peru Market by Prescription Type
        10.5.3 Peru Market by Application
        10.5.4 Peru Market by Forecast
Part 11 Middle East & Africa Market Status and Future Forecast
    11.1 Middle East & Africa Market by Region
    11.2 Middle East & Africa Market by Company
    11.3 Middle East & Africa Market by Drug Type
    11.4 Middle East & Africa Market by Prescription Type
    11.5 Middle East & Africa Market by Application
    11.6 Middle East & Africa Market by Forecast
Part 12 Middle East & Africa Market by Geography
    12.1 GCC Market Status and Future Forecast
        12.1.1 GCC Market by Drug Type
        12.1.2 GCC Market by Prescription Type
        12.1.3 GCC Market by Application
        12.1.4 GCC Market by Forecast
    12.2 North Africa Market Status and Future Forecast
        12.2.1 North Africa Market by Drug Type
        12.2.2 North Africa Market by Prescription Type
        12.2.3 North Africa Market by Application
        12.2.4 North Africa Market by Forecast
    12.3 South Africa Market Status and Future Forecast
        12.3.1 South Africa Market by Drug Type
        12.3.2 South Africa Market by Prescription Type
        12.3.3 South Africa Market by Application
        12.3.4 South Africa Market by Forecast
Part 13 Key Companies
    13.1 Ironwood Pharmaceuticals Inc
        13.1.1 Company Profile
        13.1.2 Products & Services Overview
        13.1.3 Sales Data List
    13.2 Daiichi Sankyo Co Ltd
    13.3 Pfizer
    13.4 Progenics Pharmaceuticals Inc
    13.5 Shionogi & Co., Ltd
    13.6 Allergan Plc
    13.7 Nektar Therapeutics
    13.8 Purdue Pharma
    13.9 S.L.A. Pharma AG
    13.10 Mundipharma International Limited
    13.11 Ono Pharmaceutical Co., Ltd
    13.12 Takeda Pharmaceutical Company Limited
    13.13 Theravance Biopharma Inc
    13.14 Valeant Pharmaceuticals International
    13.15 Cosmo Pharmaceuticals SA
    13.16 Daewoong Pharmaceutical
    13.17 C.B. Fleet Company
    13.18 Sucampo Pharmaceuticals
Part 14 Conclusion